Overview

Methylphenidate Study in Young Children With Developmental Disorders

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if methylphenidate (a common brand name is Ritalin), a medicine used for treating older children with Attention Deficit and Hyperactivity Disorder (ADHD), is also safe and helpful for problems related to symptoms of ADHD in young children with Developmental Disorders (DD)
Phase:
Phase 4
Details
Lead Sponsor:
University of Arizona
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Methylphenidate